# Clinical Study of Umbilical Cord Mesenchymal Stem Cells Infusion for Aging Frailty

> **NCT04314011** · PHASE1,PHASE2 · COMPLETED · sponsor: **Shanghai East Hospital** · enrollment: 30 (actual)

## Conditions studied

- Aging Frailty

## Interventions

- **BIOLOGICAL:** Human umbilical cord mesenchymal stem cells（HUC-MSCs）
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT04314011
- **Lead sponsor:** Shanghai East Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-01
- **Primary completion:** 2021-12-30
- **Final completion:** 2022-03-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04314011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04314011, "Clinical Study of Umbilical Cord Mesenchymal Stem Cells Infusion for Aging Frailty". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04314011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*